New clinical trials in Serbia: 187 since Nov 2024

Name: New clinical trials in Serbia
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New clinical trials with a site in Serbia: 187 rows for $9.35, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 4 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/serbia, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 6, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

187 clinical studies with a site in Serbia were first posted on ClinicalTrials.gov from November 12, 2024 to November 6, 2026; 118 have an industry sponsor and 113 are recruiting or about to. The newest, NCT07923253, was posted on November 6, 2026: Prospective Study of TVRFA Treatment for FIGO Type 3-5 Uterine Fibroids (University of Novi Sad).

The request: Every new clinical trial with a site in Serbia, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

187New trials
118Industry sponsored
113Recruiting or not yet
November 6, 2026Latest posted

Newest trials

The newest 100 of 187, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 6, 2026	NCT07923253	Prospective Study of TVRFA Treatment for FIGO Type 3-5 Uterine Fibroids	University of Novi Sad	Not applicable	Active not recruiting	Leiomyoma (Uterine Fibroids)	50	Serbia	clinicaltrials.gov
October 29, 2026	NCT07903259	Effect of Paracetamol Administration Timing on Oxidative Stress in Children Undergoing Sevoflurane Anesthesia	University of Belgrade	Phase 4	Completed	Oxidative Stress, Sevoflurane Anaesthesia	49	Serbia	clinicaltrials.gov
October 21, 2026	NCT07886749	Corrective Multisport Training	University of Novi Sad	Not applicable	Completed	Postural Alignment, Posture	398	Serbia	clinicaltrials.gov
October 21, 2026	NCT07885891	Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia	Wockhardt	Phase 3	Not yet recruiting	Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP)	324	Bosnia and Herzegovina, Bulgaria, Croatia, France, Georgia, Greece, India...	clinicaltrials.gov
October 15, 2026	NCT07876180	Effects of High-Intensity Interval Training and Exercise Snacking on Glycemic Control and Cardiorespiratory Fitness in Adults With Type 2...	University of Nis	Not applicable	Completed	Typ 2 Diabetes	60	Serbia	clinicaltrials.gov
October 14, 2026	NCT07874139	Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasE	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	Observational	Recruiting	Chronic Lung Diseases	683	Albania, Australia, Belgium, Brazil, Canada, China, Croatia, Czechia, Denmark...	clinicaltrials.gov
September 29, 2026	NCT07845487	A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis	Palisade Bio	Phase 2	Recruiting	Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis	204	Canada, Czechia, France, Georgia, Hungary, Italy, Latvia, Poland, Romania...	clinicaltrials.gov
August 28, 2026	NCT07793149	Comparison of KIRA Hydrating Treatment and Jet Peel for Facial Skin Hydration	Faculty of Pharmacy Novi Sad	Not applicable	Completed	Facial Skin Hydration, Skin Rejuvenation	23	Serbia	clinicaltrials.gov
August 27, 2026	NCT07791069	International Multicenter Outcomes of Transcatheter Pulmonary Flow Restrictors in Congenital and Acquired Heart Disease	Fondation Hôpital Saint-Joseph	Observational	Enrolling by invitation	Congenital Heart Disease	150	France, Germany, Serbia, United Arab Emirates, United Kingdom	clinicaltrials.gov
August 27, 2026	NCT07789015	A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies	Boehringer Ingelheim	Phase 3	Not yet recruiting	Idiopathic Inflammatory Myopathies	270	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czechia...	clinicaltrials.gov
August 24, 2026	NCT07783399	The Effects of Carnitine Supplementation on Oocytes in Women Undergoing IVF Process	The Obstetrics and Gynaecology Clinic Narodni Front	Not applicable	Recruiting	Infertility (IVF Patients)	70	Serbia	clinicaltrials.gov
August 10, 2026	NCT07753993	A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.	AstraZeneca	Phase 3	Recruiting	Chronic Kidney Disease	7,000	Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark...	clinicaltrials.gov
August 4, 2026	NCT07745504	A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight	Novo Nordisk A/S	Phase 3	Recruiting	Overweight, Obesity	285	Greece, Hungary, Portugal, Serbia, Sweden, United States	clinicaltrials.gov
August 4, 2026	NCT07743918	Vitamin D Status and Clinical Outcomes in Locally Advanced Cervical Cancer	University of Kragujevac	Observational	Recruiting	Locally Advanced Cervical Cancer, Vitamin D Concentration	100	Serbia	clinicaltrials.gov
July 20, 2026	NCT07715474	ALIGN-ACS Pilot Study	HeartBeam, Inc.	Observational	Active not recruiting	Acute Coronary Syndromes	120	Serbia	clinicaltrials.gov
July 17, 2026	NCT07709949	Does Daily Physical Education Improve Motor Skill Development and Health-Related Physical Fitness in Preschool Children?	University of Novi Sad	Not applicable	Completed	Motor Activity, Motor Coordination, Child Development, Excercise, Physical Education and Training/Methods	323	Serbia	clinicaltrials.gov
July 13, 2026	NCT07698951	Evaluating Percutaneous Repair Of The Atrial Septum With A Novel PFO Occluder: The PROTEA-PFO OUS Study	Recross Cardio, Inc.	Not applicable	Recruiting	PFO, PFO - Patent Foramen Ovale, Cryptogenic Stroke, Patent Foramen Ovale, PFO-associated Stroke	15	Serbia	clinicaltrials.gov
July 9, 2026	NCT07691970	Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From...	AstraZeneca	Phase 3	Recruiting	Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus	1,072	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
July 6, 2026	NCT07685379	A Study Comparing Real and Sham Repetitive Transcranial Magnetic Stimulation in Adults With Fibromyalgia, Assessing Effects on Pain...	Institute of Rheumatology, Serbia	Not applicable	Completed	Fibromyalgia Syndrome	30	Serbia	clinicaltrials.gov
July 6, 2026	NCT07683325	NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's...	Agomab Spain S.L.U.	Phase 2	Recruiting	Fibrostenotic Crohn's Disease	320	Serbia, United Kingdom, United States	clinicaltrials.gov
June 30, 2026	NCT07677059	A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study	Kymera Therapeutics, Inc.	Phase 2	Recruiting	Asthma (Diagnosis)	264	Germany, Poland, Serbia, United States	clinicaltrials.gov
June 26, 2026	NCT07671963	Bone Substitutes and NIPSA in Intrabony Periodontal Defects: A Randomized Controlled Trial	University of Belgrade	Not applicable	Recruiting	Periodontitis (Stage 3), Minimally Invasive Surgical Procedures, Bone Substitutes	30	Italy, Serbia	clinicaltrials.gov
June 17, 2026	NCT07655388	Wound Healing, Dressing Type, and Dressing Change Frequency in THA	Clinical Center of Vojvodina	Not applicable	Recruiting	Wound Healing Time, Total Hip Arthroplasty (THA)	90	Serbia	clinicaltrials.gov
June 17, 2026	NCT07652294	Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD	Spyre Therapeutics, Inc.	Phase 2	Enrolling by invitation	Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative	645	Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Georgia...	clinicaltrials.gov
June 15, 2026	NCT07647406	Intraseptal and Periodontal Ligament Anaesthesia for Tooth Extraction in Patients With Type 2 Diabetes	University of Business Academy in Novi Sad, Serbia	Not applicable	Completed	Diabetes Mellitus Type 2	120	Serbia	clinicaltrials.gov
June 8, 2026	NCT07633288	A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With...	SynAct Pharma Aps	Phase 2	Recruiting	Respiratory Viral Infection	96	Bosnia and Herzegovina, Montenegro, New Zealand, Serbia	clinicaltrials.gov
June 5, 2026	NCT07630714	A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years...	AstraZeneca	Phase 2	Recruiting	Systemic Lupus Erythematosus	24	Australia, Belgium, Chile, Israel, Japan, Netherlands, Peru, Philippines...	clinicaltrials.gov
June 4, 2026	NCT07625644	BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)	SystImmune Inc.	Phase 3	Recruiting	Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc, SCLC,Extensive Stage, Lung...	550	Australia, Bulgaria, Canada, Czechia, France, Georgia, Germany, Greece...	clinicaltrials.gov
June 1, 2026	NCT07618676	The 50:50 Nitrous Oxide vs 2% Lidocaine Challenge	Institute for Oncology and Radiology of Serbia	Not applicable	Completed	Acute Pain, Anxiety, Central Venous Catheter	62	Serbia	clinicaltrials.gov
June 1, 2026	NCT07618130	Opioid-Free Anesthesia and Pain Study in Cardiac Surgery Patients	Clinical Centre of Serbia	Not applicable	Not yet recruiting	Posoperativ Pain, Chronich Pain, Postoperativ Delirum, Opoid-free Managment	400	Serbia	clinicaltrials.gov
May 8, 2026	NCT07576686	AI-Guided CBT for Depression and Anxiety	Aleksandra Stojanovic	Not applicable	Recruiting	Depression - Major Depressive Disorder, Anxiety Disorders	120	Serbia	clinicaltrials.gov
May 7, 2026	NCT07574099	Loading Protocols for Dental Implants Placed in Healed Fully Edentulous Maxilla	University of Belgrade	Not applicable	Active not recruiting	Maxilla, Tooth Loss / Rehabilitation	24	Serbia	clinicaltrials.gov
April 30, 2026	NCT07559903	ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)	Emory University	Observational	Recruiting	Coronary Artery Disease	5,000	Germany, Serbia, United States	clinicaltrials.gov
April 14, 2026	NCT07527741	A Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants After Treatment...	Hoffmann-La Roche	Observational	Recruiting	Early-stage HER2+ Breast Cancer	100	Serbia	clinicaltrials.gov
April 13, 2026	NCT07525375	A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in...	AstraZeneca	Phase 2	Recruiting	Asthma	69	Argentina, Czechia, Hungary, Mexico, Poland, Serbia, United States	clinicaltrials.gov
March 31, 2026	NCT07503873	A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative...	TG Therapeutics, Inc.	Phase 2	Recruiting	Multiple Sclerosis	350	Bosnia and Herzegovina, Georgia, North Macedonia, Poland, Serbia, Ukraine	clinicaltrials.gov
March 24, 2026	NCT07491666	Effects of Neuromuscular Exercises on Motor Skills in Girls	University of Novi Sad	Not applicable	Completed	Motor Skills, Locomotor Activity, Objective Control Skills	79	Serbia	clinicaltrials.gov
March 20, 2026	NCT07485933	Comparison of Cerebral Oximetry and Neurological Status Testing in the Awake Patient in the Detection of Cerebral Ischemia During Carotid...	Clinic for Vascular and Endovascular Surgery, University Clinical Center of Serbia	Not applicable	Active not recruiting	Carotid Arteriosclerosis, Near Infrared Spectroscopy	160	Serbia	clinicaltrials.gov
March 19, 2026	NCT07483827	A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy	eleva GmbH	Phase 1	Recruiting	C3 Glomerulopathy (C3G), Healthy Adult Participants	39	Austria, Belgium, Czechia, France, Greece, Latvia, Lithuania, Netherlands...	clinicaltrials.gov
March 18, 2026	NCT07481409	A Strategy for Fall Prevention in Aging Women	University of Novi Sad	Not applicable	Completed	Fall Prevention, Functional Independence, Balance Impairment	32	Serbia	clinicaltrials.gov
March 17, 2026	NCT07477587	A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With...	Shanghai Henlius Biotech	Phase 1	Recruiting	Multiple Myeloma (MM)	258	Australia, China, Georgia, Serbia, United States	clinicaltrials.gov
March 17, 2026	NCT07476326	Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma	Biocon Biologics UK PLC	Phase 1	Recruiting	Melanoma	120	Brazil, Chile, Georgia, Moldova, Romania, Serbia, South Africa, Spain, Turkey...	clinicaltrials.gov
March 16, 2026	NCT07473700	Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease	Tectonic Operating Company, Inc.	Phase 2	Recruiting	Hypertension, Pulmonary, Lung Diseases, Interstitial	25	Poland, Romania, Serbia, South Korea, Spain, United States	clinicaltrials.gov
February 27, 2026	NCT07438496	A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus	Janssen Research & Development, LLC	Phase 3	Recruiting	Lupus Erythematosus, Systemic	600	Argentina, Australia, Brazil, Bulgaria, China, Czechia, Denmark, Finland...	clinicaltrials.gov
February 23, 2026	NCT07425990	FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles	University of Novi Sad	Not applicable	Recruiting	Infertility Female, Frozen Embryo Transfer (FET)	120	Serbia	clinicaltrials.gov
February 19, 2026	NCT07421986	Elastic Band Exercise to Improve Hip Strength and Agility in Young Basketball Players	Nebojša Trajković	Not applicable	Completed	Eccentric Exercise Training, Strength Training Effects, Strengthening Exercises, Hip Adduction Strength, Healthy...	21	Serbia	clinicaltrials.gov
February 18, 2026	NCT07416721	Cooling of the Knee After Total Knee Arthroplasty	Clinical Center of Vojvodina	Not applicable	Completed	Osteoarthritis, Knee, Total Knee Replacement	99	Serbia	clinicaltrials.gov
February 17, 2026	NCT07415044	LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis	Eli Lilly and Company	Phase 2	Recruiting	Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe	1,431	Argentina, Brazil, Canada, China, Colombia, Croatia, Czechia, France, Greece...	clinicaltrials.gov
February 17, 2026	NCT07414433	Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma	University of Belgrade	Observational	Not yet recruiting	Hepatocellular Carcinoma (HCC), Liver Neoplasms	60	Serbia	clinicaltrials.gov
February 17, 2026	NCT07414420	Oral Dynamic Propulsion Appliance in Treatment of Patients With Obstructive Sleeping Apnea	University of Belgrade	Not applicable	Not yet recruiting	Obstructive Sleep Apnea (OSA)	40	Serbia	clinicaltrials.gov
February 13, 2026	NCT07410065	Supersaturated Hydrogen-Rich Water for Outpatients With Persistent Excess Weight	Center for Health Sciences, Serbia	Not applicable	Not yet recruiting	Overweight	120	Serbia	clinicaltrials.gov
February 13, 2026	NCT07409181	A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)	Boehringer Ingelheim	Phase 2	Recruiting	Systemic Lupus Erythematosus	405	Argentina, Australia, Brazil, Bulgaria, China, Colombia, Croatia, Germany...	clinicaltrials.gov
February 13, 2026	NCT07409103	A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate...	Elevara Medicines Limited	Phase 2	Recruiting	Active Rheumatoid Arthritis	180	Serbia, South Africa, United States	clinicaltrials.gov
February 12, 2026	NCT07405840	Application of Autologous Stem Cells From Adipose Tissue in the Regeneration of Knee Joint Cartilage	Clinical Center of Vojvodina	Phase 4	Active not recruiting	Osteearthritis	60	Serbia	clinicaltrials.gov
February 10, 2026	NCT07401381	A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone...	Rovi Pharmaceuticals Laboratories	Phase 1	Recruiting	Hormone Receptor Positive Early Breast Cancer	120	Serbia, Spain, United States	clinicaltrials.gov
February 9, 2026	NCT07395219	European TIF2.0 Registry	Cleveland Clinic London	Observational	Enrolling by invitation	Gastro -Oesophagal Reflux, Laryngo-pharyngeal Reflux	500	Austria, Italy, Serbia, Switzerland, Turkey (Türkiye), United Arab Emirates...	clinicaltrials.gov
February 6, 2026	NCT07393789	A Multicomponent Physical Activity Intervention Effect on Weekly Steps and Physical Fitness in Preadolescents	University of Belgrade	Not applicable	Completed	Multicomponent 16-week Program Comprised of a Goal Setting, Wearable Activity Tracker Feedback, Physical Exercising...	178	Czechia, Serbia	clinicaltrials.gov
February 6, 2026	NCT07391813	SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer	SN BioScience	Phase 1/2	Recruiting	Patient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell...	55	Serbia	clinicaltrials.gov
February 4, 2026	NCT07387575	Screening in Relatives With Elevated Risk for Unruptured Intracranial Aneurysms	University of Novi Sad	Observational	Enrolling by invitation	Intracranial Aneurysms, Subarachnoid Hemorrhage, Aneurysmal	300	Serbia	clinicaltrials.gov
January 30, 2026	NCT07378709	Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma	University of Belgrade	Observational	Recruiting	Hepatocellular Carcinoma (HCC), Liver Neoplasms	15	Serbia	clinicaltrials.gov
January 26, 2026	NCT07366684	Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome	Clinical Center Niš	Observational	Recruiting	ST Elevation (STEMI) Myocardial Infarction, Non ST Elevation Myocardial Infarction (NSTEMI), Unstable Angina Pectoris	550	Serbia	clinicaltrials.gov
January 22, 2026	NCT07360899	Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture	Institute of Cardiovascular Diseases, Vojvodina	Not applicable	Recruiting	ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Atrial Fibrillation (AF), Mitral Valve Surgery, Stroke (in Patients...	200	Serbia	clinicaltrials.gov
January 22, 2026	NCT07359846	A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)	Generate Biomedicines	Phase 3	Recruiting	Severe Asthma	786	Argentina, Australia, Belgium, Estonia, France, Georgia, India, Ireland, Italy...	clinicaltrials.gov
January 22, 2026	NCT07357740	A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes	Novo Nordisk A/S	Phase 2	Withdrawn	Diabetes Mellitus, Type 2	0	Denmark, Greece, Malaysia, Serbia, Slovakia, Spain, Thailand, United States	clinicaltrials.gov
January 20, 2026	NCT07351149	Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery	Uppsala University	Observational	Recruiting	Acute Kidney Injury	2,000	Australia, Brazil, Canada, Croatia, France, Italy, Netherlands, Serbia, Sweden...	clinicaltrials.gov
January 20, 2026	NCT07349953	Correlation Between Anthropometric Characteristics and Age-based Formulas for Uncuffed Pediatric Endotracheal Tube	Mother and Child Health Institute of Serbia Dr Vukan Cupic	Observational	Completed	Endotracheal Tube, Finger	103	Serbia	clinicaltrials.gov
January 13, 2026	NCT07337759	Fetus Programming and Long Active Outcomes, Interaction Between Mother, Placenta and Fetus in Perinatal and Methabolic...	University of Belgrade	Observational	Completed	Placental Insufficiency Hypertensive Disorders of Pregnancy Diabetes Mellitus in Pregnancy Thrombophilia in Pregnancy...	440	Serbia	clinicaltrials.gov
January 9, 2026	NCT07328906	Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome	University of Belgrade	Not applicable	Not yet recruiting	Postimplantation Syndrome, Myocardial Injury, MACE, Mortality	174	Serbia	clinicaltrials.gov
January 7, 2026	NCT07323654	A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma	Kymera Therapeutics, Inc.	Phase 2	Recruiting	Eosinophilic Asthma	264	Argentina, Austria, Belgium, Germany, Italy, Poland, Romania, Serbia, Slovakia...	clinicaltrials.gov
January 5, 2026	NCT07317830	Effects of Different Vitamin D3 Formulations in Vitamin D-Deficient Adults	Center for Health Sciences, Serbia	Not applicable	Recruiting	Vitamin D Deficiency	20	Serbia	clinicaltrials.gov
December 26, 2025	NCT07304843	A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With...	Umecrine Cognition AB	Phase 1/2	Completed	Primary Biliary Cholangitis (PBC)	207	Germany, Greece, Hungary, Italy, Serbia, Spain, Turkey (Türkiye), United Kingdom	clinicaltrials.gov
December 24, 2025	NCT07301736	Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma	Chiesi Farmaceutici S.p.A.	Phase 2	Recruiting	Asthma	780	Argentina, Bosnia and Herzegovina, Bulgaria, Czechia, Germany, Hungary, Latvia...	clinicaltrials.gov
December 23, 2025	NCT07299019	A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis	Zenas BioPharma (USA), LLC	Phase 3	Recruiting	Secondary Progressive Multiple Sclerosis	990	Australia, Belgium, Bulgaria, Croatia, Czechia, Estonia, France, Georgia...	clinicaltrials.gov
December 22, 2025	NCT07296315	Confirmatory Clinical Study in Active Ulcerative Colitis	MRM Health NV	Phase 2	Recruiting	Colitis, Ulcerative	204	Czechia, Georgia, Moldova, Poland, Serbia, Ukraine, United States	clinicaltrials.gov
December 17, 2025	NCT07288489	Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require...	VarmX B.V.	Phase 3	Recruiting	Blood Loss, Surgical, Coagulation Disorder	800	Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Hungary, Italy...	clinicaltrials.gov
December 17, 2025	NCT07288216	Transition to KPL-387 Monotherapy Dosing & Administration Study	Kiniksa Pharmaceuticals International, plc	Phase 2	Recruiting	Recurrent Pericarditis, Heart Diseases, Pericarditis	120	Canada, France, Germany, Greece, Italy, Poland, Serbia, Spain, United Kingdom...	clinicaltrials.gov
December 17, 2025	NCT07287189	Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients	Satellos Bioscience, Inc.	Phase 2	Active not recruiting	Duchenne Muscular Dystrophy, Duchenne, DMD, Neuromuscular Diseases, Muscular Dystrophies	51	Australia, Belgium, Canada, Poland, Serbia, Spain, United Kingdom, United States	clinicaltrials.gov
December 16, 2025	NCT07285226	Creatine HCl Supplementation in Sarcopenia: A Randomized Controlled Study	Center for Health Sciences, Serbia	Not applicable	Recruiting	Sarcopenia	30	Serbia	clinicaltrials.gov
December 16, 2025	NCT07284459	Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis	Contineum Therapeutics	Phase 2	Recruiting	Idiopathic Pulmonary Fibrosis	324	Argentina, Australia, Belgium, Canada, Chile, Denmark, France, Germany, Greece...	clinicaltrials.gov
December 9, 2025	NCT07272694	Split Crest Procedure: Is It Necessary to Fill the Gap?	Vladimir Biocanin	Not applicable	Completed	Alveolar Bone Resorption, Alveolar Bone Grafting, Bone Expansion	24	Serbia	clinicaltrials.gov
December 5, 2025	NCT07267949	Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation	Acesion Pharma	Phase 2	Recruiting	Atrial Fibrillation (AF)	200	Bulgaria, Denmark, Germany, Hungary, Italy, Netherlands, Poland, Serbia	clinicaltrials.gov
December 2, 2025	NCT07258706	Demographic and Interpopulation Variations in Evaluation and Results of TAVI	Poznan University of Medical Sciences	Observational	Enrolling by invitation	Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Computed Tomography, Inflammatory Response During...	800	Italy, Poland, Serbia, Thailand, Turkey (Türkiye)	clinicaltrials.gov
December 2, 2025	NCT07257666	Sensory Deficit Following ACL Reconstruction: PRF Pilot Study	University of Belgrade	Observational	Completed	Anterior Cruciate Ligament Injury, Knee Injuries, Sensory Disorders, Bone-Patellar Tendon-Bone Autograft, Platelet-Rich...	53	Serbia	clinicaltrials.gov
November 28, 2025	NCT07253285	A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight	Novo Nordisk A/S	Phase 3	Recruiting	Overweight, Obesity	460	Australia, Austria, Belgium, Bulgaria, China, Colombia, Croatia, Denmark...	clinicaltrials.gov
November 26, 2025	NCT07251933	A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries	Takeda	Observational	Completed	Hereditary Angioedema (HAE)	37	Argentina, France, Germany, Israel, Serbia, United Kingdom	clinicaltrials.gov
November 26, 2025	NCT07250750	A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis	ImmunAbs Inc.	Phase 1/2	Recruiting	Myasthenia Gravis	96	Bulgaria, Italy, Poland, Serbia, Spain, United States	clinicaltrials.gov
November 25, 2025	NCT07249333	Perioperative Complications After Neoadjuvant Radiotherapy for Colorectal Cancer	Oncology Institute of Vojvodina	Observational	Recruiting	Colorectal Cancer, Neoadjuvant Radiotherapy, Perioperative Complication	80	Serbia	clinicaltrials.gov
November 21, 2025	NCT07241390	A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney...	Eli Lilly and Company	Phase 3	Recruiting	Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease	7,140	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China...	clinicaltrials.gov
November 17, 2025	NCT07230288	Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis	AbbVie	Phase 2	Recruiting	Idiopathic Pulmonary Fibrosis	165	Australia, Bulgaria, Canada, France, Germany, Greece, Japan, Poland, Portugal...	clinicaltrials.gov
November 13, 2025	NCT07227818	Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia	Neurocrine Biosciences	Phase 3	Recruiting	Schizophrenia	560	Puerto Rico, Serbia, United States	clinicaltrials.gov
October 20, 2025	NCT07218029	A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)	Merck Sharp & Dohme LLC	Phase 3	Active not recruiting	Pulmonary Arterial Hypertension	815	Argentina, Australia, Belgium, Brazil, Canada, Colombia, Croatia, Czechia...	clinicaltrials.gov
October 8, 2025	NCT07212270	Effectiveness of Intraseptal Anesthesia for Periodontal Surgical Procedures	University of Belgrade	Not applicable	Active not recruiting	Periodontitis, Gingivitis and Periodontal Diseases	60	Serbia	clinicaltrials.gov
October 8, 2025	NCT07211633	A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in...	TG Therapeutics, Inc.	Phase 3	Active not recruiting	Relapsing Multiple Sclerosis	360	Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Georgia, Hungary, North...	clinicaltrials.gov
October 2, 2025	NCT07204886	Impact of Multicomponent and Stability Training on Fitness and Function in Active Older Women	University of Novi Sad	Not applicable	Completed	Body Composition, Physical Fitness, Functional Capacities	40	Serbia	clinicaltrials.gov
September 29, 2025	NCT07196501	A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Neurocrine Biosciences	Phase 3	Recruiting	Major Depressive Disorder	550	Australia, Bulgaria, Canada, Estonia, Italy, Poland, Serbia, South Korea...	clinicaltrials.gov
September 26, 2025	NCT07194850	A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)	argenx	Phase 2/3	Recruiting	Immune Thrombocytopenia (ITP), ITP - Immune Thrombocytopenia, ITP, Immune Thrombocytopenic Purpura, Immune...	24	France, Germany, Italy, Japan, Lithuania, Poland, Romania, Serbia, Spain...	clinicaltrials.gov
September 23, 2025	NCT07188844	An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)	Immunovant Sciences GmbH	Phase 2	Terminated	Chronic Inflammatory Demyelinating Polyneuropathy	26	Argentina, Belgium, Brazil, Germany, Greece, Italy, Poland, Romania, Serbia...	clinicaltrials.gov
September 22, 2025	NCT07185009	A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative...	Sanofi	Phase 3	Recruiting	Ulcerative Colitis	751	Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
September 22, 2025	NCT07184996	An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis	Sanofi	Phase 3	Recruiting	Ulcerative Colitis	980	Argentina, Australia, Austria, Bulgaria, Canada, China, Czechia, France...	clinicaltrials.gov
September 22, 2025	NCT07184944	A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease	Sanofi	Phase 3	Recruiting	Crohn's Disease	751	Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia...	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
University of Belgrade	12	October 29, 2026
University of Novi Sad	11	November 6, 2026
AstraZeneca	6	August 10, 2026
AbbVie	5	November 17, 2025
Neurocrine Biosciences	5	November 13, 2025
Sanofi	5	September 22, 2025
Boehringer Ingelheim	4	August 27, 2026
Clinical Center of Vojvodina	4	June 17, 2026
argenx	4	September 26, 2025
Immunovant Sciences GmbH	4	September 23, 2025
University of Novi Sad, Faculty of Sport and Physical Education	4	May 13, 2025
Novo Nordisk A/S	3	August 4, 2026
Center for Health Sciences, Serbia	3	February 13, 2026
University of Kragujevac	2	August 4, 2026
Kymera Therapeutics, Inc.	2	June 30, 2026
Spyre Therapeutics, Inc.	2	June 17, 2026
Hoffmann-La Roche	2	April 14, 2026
TG Therapeutics, Inc.	2	March 31, 2026
Eli Lilly and Company	2	February 17, 2026
Institute of Cardiovascular Diseases, Vojvodina	2	January 22, 2026

Conditions

Condition group	New trials	Latest
Colitis, Ulcerative	8	September 29, 2026
Asthma	5	June 30, 2026
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	5	September 23, 2025
Heart Failure	5	April 20, 2025
Inflammatory Bowel Diseases	4	September 29, 2026
Obesity	4	August 4, 2026
Lung Diseases, Interstitial	4	March 16, 2026
Stroke	4	February 4, 2026
Myasthenia Gravis	4	November 26, 2025
Autoimmune Diseases	4	September 23, 2025
Hypertension	4	September 18, 2025
Colitis	3	September 29, 2026
Renal Insufficiency, Chronic	3	August 10, 2026
Overweight	3	August 4, 2026
Acute Coronary Syndrome	3	July 20, 2026
Diabetes Mellitus, Type 2	3	June 15, 2026
Lupus Erythematosus, Systemic	3	June 5, 2026
Anxiety Disorders	3	June 1, 2026
Atrial Fibrillation	3	January 22, 2026
Schizophrenia	3	November 13, 2025
Purpura, Thrombocytopenic, Idiopathic	3	September 26, 2025
Carcinoma, Non-Small-Cell Lung	3	September 4, 2025
Pulmonary Disease, Chronic Obstructive	3	May 20, 2025
Myositis	2	August 27, 2026
Vitamin D Deficiency	2	August 4, 2026

By phase

Phase	New trials	Latest
Phase 3	55	October 21, 2026
Not applicable	49	November 6, 2026
Phase 2	39	September 29, 2026
Observational	27	October 14, 2026
Phase 1/2	6	February 6, 2026
Phase 2/3	5	September 26, 2025
Phase 1	4	March 19, 2026
Phase 4	2	October 29, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.